Research Article
BibTex RIS Cite
Year 2025, Volume: 16 Issue: Erken Çevrimiçi Yayınlar
https://doi.org/10.31067/acusaglik.1486442

Abstract

References

  • 1. Yan T, Simone DB, Cherubino et al. 2:1 ketogenic diet and low-glycemic-index diet for the treatment of chronic and episodic migraine: a single-center real-life retrospective study, J. Headache Pain. 2023;24:95-8. DOI: 10.1186/s10194-023-01635-9
  • 2. Burch RC, Loder S, Loder E et al. The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache. 2015;55:21-34. DOİ: 10.1111/head.12482.
  • 3. Vos T, Flaxman AD, Naghavi M et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the global burden of disease study 2010. The Lancet. 2013;380:2163-2196. DOİ: 10.1016/ S0140-6736(12)61729-2
  • 4. Shahnaz AT, Arghavan B, Maryam K et al. The predictive role of the dietary phytochemical index in relation to the clinical and psychological traits of migraine headaches, Sci. Rep.2024;14:6886-11. DOI: 10.1038/s41598-024-57536-7
  • 5. Hsueh-Fang W, Wen-Chun L, Halliru Z et al. A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine. BBI – Health.2024;118:459–67. DOI: 10.1016/j.bbi.2024.03.019
  • 6. Headache Classification Committee of the International Headache Society. The International Classification of headache disorders. Cephalalgia. 2013;33:629-808. DOİ: 10.1186/s10194-023-01659-1
  • 7. Peter JG, Stefan E, Amy AG, Richard BL et al. International Classification of Headache Disorders-4–Work in Progress 1. Cephalalgia 2024;44(2):1–2. DOI: 10.1177/03331024241233937
  • 8. Rikki M, Alexandra LB, Maya TG et al. Wirth, the impacts of migraine on functioning: Results from two qualitative studies of people living with migraine, Headache. 2024;64:156–171. DOI: 10.1111/head.14664
  • 9. Diamond S, Bigal ME, Silberstein S et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention study. Headache. 2007;47:355-63. DOI: 10.1111/j.1526-4610.2006.00631.x
  • 10. Lipton RB, Serrano D, Holland S et al. Barriers to the diagnosis and treatment of migraine: Effects of sex, income, and headache features. Headache. 2013;53:81-92. DOİ: 10.1111/j.1526-4610.2012.02265.x
  • 11. Puledda F and Shields K. Non-pharmacological approaches for migraine. Neurotherapeutics.2018;15:336–345. DOİ: 10.1007/s13311-018-0623-6
  • 12. Coppola G, Di Lorenzo C, Serrao M et al. Pathophysiological targets for non-pharmacological treatment of migraine. Cephalalgia. 2016;36:1103–11. DOİ: 10.1177/0333102415620908
  • 13. Altamura C, Cecchi G, Bravo M et al. The healthy eating plate advice for Migraine Prevention: an interventional study. Nutrients 2020;12:1-11 DOİ:10.3390/nu12061579.
  • 14. Arab A, Khorvash F, Kazemi M et al. Efects of the Dietary Approaches to stop hypertension (DASH) diet on clinical, quality of life and mental health outcomes in women with migraine: a randomized controlled trial. Br J Nutr.2022;128:1535–1544. DOI: 10.1017/S000711452100444X
  • 15. Yücel Y. Migren baş ağrısında tanı ve tedavi yaklaşımları. Dicle Tip Derg, 2008;35(4):281-286.
  • 16. Antonio LAS, Javier AM and Javier DT. Migraine review for general practice. Aten Primaria. 2021;54:102208-8. DOI: 10.1016/j.aprim.2021.102208
  • 17. Gaul C, Diener HC and Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, doubleblind, multicenter trial. J Headache Pain. 2015;16:6-13. DOI: 10.1186/s10194-015-0516-6
  • 18. Asmaa YE, Naglaa AS and Randa E. Frequency and risk factors for headache disability: A population based cross sectional study in Egypt. J Family Community Med. 2023;30(4):300-6 DOİ:10.4103/jfcm.jfcm_51_23 19. Tanik N, Celikbilek A, Metin A, Gocmen AY et al. Retinol-binding protein-4 and hs-CRP levels in patients with migraine. Neurol Sci. 2015;36(10):1823-7. DOİ: 10.1007/s10072-015-2262-6.
  • 20. Schurgers LJ and Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis. 2000; 30:298–307. DOI: 10.1159/000054147
  • 21. Castro Q, Román V and Serra-Majem L. The mediterranean diet and nutritional adequacy: a review. Nutrients; 2014;6(1):231-48. DOİ: 10.3390/nu6010231
  • 22. Shea MK, Booth SL and Miller ME. Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults: The Multi-Ethnic Study of Atherosclerosis. Thromb Haemost.2014;112(3):438–444. DOİ: 10.1160/TH13-12-1003
  • 23. John Visser E, Drummond PD and Lee-Visser JLA. Reduction in migraine and headache frequency and ıntensity with combined antioxidant prophylaxis (n-acetylcysteine, vitamin e and vitamin c: nec): a randomized sham-controlled pilot study. Pain Pract 2020;20:737-747. DOİ: 10.1111/papr.12902.
  • 24. Xin yu L, Cheng hao Y, Jia jie L et al. Global, regional, and national epidemiology of migraine and tension-type headache in youths and young adults aged 15–39 years from 1990 to 2019: findings from the global burden of disease study 2019. J Headache Pain.2023;24(126):1-17. DOİ: 10.1186/s10194-023-01659-1
  • 25. Pinto E, Viegas C, Martins PM et al. Mediterranean diet favors vitamin k ıntake: a descriptive study in a mediterranean population. Nutrients. 2024;16(8):1-12. DOİ: 10.3390/nu16081098
  • 26. Serra-Majem L and Medina FX. Mediterranean diet: A long journey toward intangible cultural heritage and sustainability. The mediterranean diet: an evidence-based approach; Academic press; 2020.p. 13–24. DOI: 10.1016/B978-0-12-818649-7.00002-3
  • 27. Borkum JM. Migraine triggers and oxidative stress: a narrative review and synthesis. Headache 2016;56(1):12–35. DOI: 10.1111/head.12725
  • 28. Ooi L, Gigout S, Pettinger L and Gamper N. Triple cysteine module within M-type K+ channels mediates reciprocal channel modulation by nitric oxide and reactive oxygen pecies. J Neurosci 2013;33(14):6041–46. DOİ: 10.1523/JNEUROSCI.4275-12.2013
  • 29. Finsterer J and Zarrouk-Mahjoub S. Headache in mitochondrial disorders. Clin Neurol Neurosurg 2018;166:44–9. DOI: 10.1016/j.clineuro.2018.01.020
  • 30. Fossıer P, Blanchard B, Ducrocq C et al. Nıtrıc oxıde transforms serotonın ınto an ınactıve form and thıs affects neuromodulatıon. Neuroscience. 1999;93(2):597-603. DOİ: 10.1016/s0306-4522(99)00165-7.

Investigation of The Relationship Between Primary Headache Severity and Daily Food Preferences in Young Adults not yet Diagnosed with Migraine

Year 2025, Volume: 16 Issue: Erken Çevrimiçi Yayınlar
https://doi.org/10.31067/acusaglik.1486442

Abstract

Purpose: Migraine is a complex neurological disease. The aim of our study is to provide sustainable food-mediated benefit in migraine prophylaxis to people with severe symptoms who have not yet been diagnosed with migraine.
Methods: The study included 197 people between the ages of 18-45 who had not yet been diagnosed with migraine had strong symptoms, had no metabolic disease, psychiatric disease or disability. In the first stage of the study the internationally used “Headache Disability Index” scale was applied to the participants. After 4 weeks of consuming the recommended reference foods, the Headache Disability Index test was repeated and the score difference was accepted as data.Evaluation of the data SPSS 26 statistical program was used and p<0.05 was considered significant.
Results: The inclusion of liver as a reference food in the diet resulted in a significant improvement in the Headache Disability Index F19 (p<0.003) recommendation, and the inclusion of broccoli provided statistically significant improvements in the E9 (p<0.039) and F13 (p<0.025) recommendations.
Conclusion: In people with severe migraine symptoms; Providing only the daily recommended amounts of vitamins A, B12, K1 and C to their diet through broccoli and liver foods; It provided improvement in emotional and functional disabilities.

References

  • 1. Yan T, Simone DB, Cherubino et al. 2:1 ketogenic diet and low-glycemic-index diet for the treatment of chronic and episodic migraine: a single-center real-life retrospective study, J. Headache Pain. 2023;24:95-8. DOI: 10.1186/s10194-023-01635-9
  • 2. Burch RC, Loder S, Loder E et al. The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache. 2015;55:21-34. DOİ: 10.1111/head.12482.
  • 3. Vos T, Flaxman AD, Naghavi M et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the global burden of disease study 2010. The Lancet. 2013;380:2163-2196. DOİ: 10.1016/ S0140-6736(12)61729-2
  • 4. Shahnaz AT, Arghavan B, Maryam K et al. The predictive role of the dietary phytochemical index in relation to the clinical and psychological traits of migraine headaches, Sci. Rep.2024;14:6886-11. DOI: 10.1038/s41598-024-57536-7
  • 5. Hsueh-Fang W, Wen-Chun L, Halliru Z et al. A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine. BBI – Health.2024;118:459–67. DOI: 10.1016/j.bbi.2024.03.019
  • 6. Headache Classification Committee of the International Headache Society. The International Classification of headache disorders. Cephalalgia. 2013;33:629-808. DOİ: 10.1186/s10194-023-01659-1
  • 7. Peter JG, Stefan E, Amy AG, Richard BL et al. International Classification of Headache Disorders-4–Work in Progress 1. Cephalalgia 2024;44(2):1–2. DOI: 10.1177/03331024241233937
  • 8. Rikki M, Alexandra LB, Maya TG et al. Wirth, the impacts of migraine on functioning: Results from two qualitative studies of people living with migraine, Headache. 2024;64:156–171. DOI: 10.1111/head.14664
  • 9. Diamond S, Bigal ME, Silberstein S et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention study. Headache. 2007;47:355-63. DOI: 10.1111/j.1526-4610.2006.00631.x
  • 10. Lipton RB, Serrano D, Holland S et al. Barriers to the diagnosis and treatment of migraine: Effects of sex, income, and headache features. Headache. 2013;53:81-92. DOİ: 10.1111/j.1526-4610.2012.02265.x
  • 11. Puledda F and Shields K. Non-pharmacological approaches for migraine. Neurotherapeutics.2018;15:336–345. DOİ: 10.1007/s13311-018-0623-6
  • 12. Coppola G, Di Lorenzo C, Serrao M et al. Pathophysiological targets for non-pharmacological treatment of migraine. Cephalalgia. 2016;36:1103–11. DOİ: 10.1177/0333102415620908
  • 13. Altamura C, Cecchi G, Bravo M et al. The healthy eating plate advice for Migraine Prevention: an interventional study. Nutrients 2020;12:1-11 DOİ:10.3390/nu12061579.
  • 14. Arab A, Khorvash F, Kazemi M et al. Efects of the Dietary Approaches to stop hypertension (DASH) diet on clinical, quality of life and mental health outcomes in women with migraine: a randomized controlled trial. Br J Nutr.2022;128:1535–1544. DOI: 10.1017/S000711452100444X
  • 15. Yücel Y. Migren baş ağrısında tanı ve tedavi yaklaşımları. Dicle Tip Derg, 2008;35(4):281-286.
  • 16. Antonio LAS, Javier AM and Javier DT. Migraine review for general practice. Aten Primaria. 2021;54:102208-8. DOI: 10.1016/j.aprim.2021.102208
  • 17. Gaul C, Diener HC and Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, doubleblind, multicenter trial. J Headache Pain. 2015;16:6-13. DOI: 10.1186/s10194-015-0516-6
  • 18. Asmaa YE, Naglaa AS and Randa E. Frequency and risk factors for headache disability: A population based cross sectional study in Egypt. J Family Community Med. 2023;30(4):300-6 DOİ:10.4103/jfcm.jfcm_51_23 19. Tanik N, Celikbilek A, Metin A, Gocmen AY et al. Retinol-binding protein-4 and hs-CRP levels in patients with migraine. Neurol Sci. 2015;36(10):1823-7. DOİ: 10.1007/s10072-015-2262-6.
  • 20. Schurgers LJ and Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis. 2000; 30:298–307. DOI: 10.1159/000054147
  • 21. Castro Q, Román V and Serra-Majem L. The mediterranean diet and nutritional adequacy: a review. Nutrients; 2014;6(1):231-48. DOİ: 10.3390/nu6010231
  • 22. Shea MK, Booth SL and Miller ME. Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults: The Multi-Ethnic Study of Atherosclerosis. Thromb Haemost.2014;112(3):438–444. DOİ: 10.1160/TH13-12-1003
  • 23. John Visser E, Drummond PD and Lee-Visser JLA. Reduction in migraine and headache frequency and ıntensity with combined antioxidant prophylaxis (n-acetylcysteine, vitamin e and vitamin c: nec): a randomized sham-controlled pilot study. Pain Pract 2020;20:737-747. DOİ: 10.1111/papr.12902.
  • 24. Xin yu L, Cheng hao Y, Jia jie L et al. Global, regional, and national epidemiology of migraine and tension-type headache in youths and young adults aged 15–39 years from 1990 to 2019: findings from the global burden of disease study 2019. J Headache Pain.2023;24(126):1-17. DOİ: 10.1186/s10194-023-01659-1
  • 25. Pinto E, Viegas C, Martins PM et al. Mediterranean diet favors vitamin k ıntake: a descriptive study in a mediterranean population. Nutrients. 2024;16(8):1-12. DOİ: 10.3390/nu16081098
  • 26. Serra-Majem L and Medina FX. Mediterranean diet: A long journey toward intangible cultural heritage and sustainability. The mediterranean diet: an evidence-based approach; Academic press; 2020.p. 13–24. DOI: 10.1016/B978-0-12-818649-7.00002-3
  • 27. Borkum JM. Migraine triggers and oxidative stress: a narrative review and synthesis. Headache 2016;56(1):12–35. DOI: 10.1111/head.12725
  • 28. Ooi L, Gigout S, Pettinger L and Gamper N. Triple cysteine module within M-type K+ channels mediates reciprocal channel modulation by nitric oxide and reactive oxygen pecies. J Neurosci 2013;33(14):6041–46. DOİ: 10.1523/JNEUROSCI.4275-12.2013
  • 29. Finsterer J and Zarrouk-Mahjoub S. Headache in mitochondrial disorders. Clin Neurol Neurosurg 2018;166:44–9. DOI: 10.1016/j.clineuro.2018.01.020
  • 30. Fossıer P, Blanchard B, Ducrocq C et al. Nıtrıc oxıde transforms serotonın ınto an ınactıve form and thıs affects neuromodulatıon. Neuroscience. 1999;93(2):597-603. DOİ: 10.1016/s0306-4522(99)00165-7.
There are 29 citations in total.

Details

Primary Language English
Subjects Primary Health Care
Journal Section Research Articles
Authors

Duygu Vardağlı 0000-0002-9022-1338

Özlem Ortakcı 0000-0002-1304-7364

Early Pub Date March 21, 2025
Publication Date
Submission Date May 19, 2024
Acceptance Date October 30, 2024
Published in Issue Year 2025Volume: 16 Issue: Erken Çevrimiçi Yayınlar

Cite

EndNote Vardağlı D, Ortakcı Ö (March 1, 2025) Investigation of The Relationship Between Primary Headache Severity and Daily Food Preferences in Young Adults not yet Diagnosed with Migraine. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 16 Erken Çevrimiçi Yayınlar